The Shaare Zedek Medical Center is a major hospital in Jerusalem established in 1902.

There are 1,000 beds in Shaare Zedek Medical Center.

During the past decade, Shaare Zedek Medical Center conducted 276 clinical trials. In the 10-year time frame, 276 clinical trials started and 92 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 124 clinical trials started and 68 clinical trials were completed. i.e. 54.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shaare Zedek Medical Center" #1 sponsor was "Shaare Zedek Medical Center" with 92 trials, followed by "Pfizer" with 18 trials sponsored, "Celgene" with 17 trials sponsored, "Hoffmann-La Roche" with 14 trials sponsored and "Shire" with 14 trials sponsored. Other sponsors include 254 different institutions and companies that sponsored additional 161 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shaare Zedek Medical Center" #1 collaborator was "Shaare Zedek Medical Center" with 10 trials as a collaborator, "Takeda Development Center Americas, Inc." with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 144 different institutions and companies that were collaborators in the rest 127 trials.

According to Clinical.Site data, the most researched conditions in "Shaare Zedek Medical Center" are "Ulcerative Colitis" (28 trials), "Crohn's Disease" (26 trials), "Gaucher Disease" (15 trials), "Breast Cancer" (8 trials) and "Crohn Disease" (8 trials). Many other conditions were trialed in "Shaare Zedek Medical Center" in a lesser frequency.

Most popular intervention types in "Shaare Zedek Medical Center" are "Drug" (269 trials), "Device" (57 trials), "Other" (43 trials), "Biological" (32 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (78 trials), "placebo" (7 trials), "Carboplatin" (6 trials), "Lenalidomide" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Shaare Zedek Medical Center" are 378 trials for "All" genders, 33 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 149 active trials in "Shaare Zedek Medical Center". 4 are not yet recruiting, 86 are recruiting, 57 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 171 completed trials in Shaare Zedek Medical Center, 4 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Shaare Zedek Medical Center, 27 "Phase 1" clinical trials were conducted, 105 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 64 trials that are defined as “Not Applicable".

Shaare Zedek Medical Center has several departments that took part in Clinical trials: "Shaare Zedek Medical Center; Oncology Dept" - 12 trials, "Digestive Diseases Institute, Shaare Zedek Medical Center" - 6 trials, "Dept. of Orthopedic Surgery, Shaare Zedek Medical Center" - 4 trials, "Neonatal Intensive Care Unit - Shaare Zedek Medical Center" - 3 trials, "Intensive Care Unit, Shaare Zedek Medical Center" - 2 trials, "Shaare Zedek Medical Center - Gastroenterology" - 2 trials, "The Center for Integrative Complementary Medicine, Shaare Zedek Medical Center" - 2 trials, "The Department of Pediatric Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University" - 2 trials, "Shaare Zedek Medical Center; Pulmonary Inst." - 2 trials, "The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center" - 2 trials